Navigation Links
Timothy J. Maines Joins Omthera Pharmaceuticals as Vice President of Quality
Date:10/25/2011

BEDMINSTER, N.J., Oct. 25, 2011 /PRNewswire/ -- Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that Timothy J. Maines has joined the Company as Vice President of Quality.  In this newly created position, reporting directly to Chief Operating Officer, Drs. Ben Machielse, Mr. Maines will be responsible for Quality, Validation and CMC development at Omthera.  

Mr. Maines brings to the Company more than 25 years of pharmaceutical, medical device and biologic experience in both the U.S. and European Union, with additional skills in biochemistry, chemistry and virology.

Commenting on today's news, Drs. Machielse stated, "Timothy is a proven Quality Executive with an extensive range of expertise in start-up, clinical and commercial operations. As Vice President of Quality, Timothy will help build a strong infrastructure for Omthera's manufacturing and quality practices.  As such, we are delighted to welcome him to the Company. His experience in bringing specialty products to market will be key as we pursue the ultimate commercialization of Epanova™, as demonstrated by Tim's contributions to the approval of ATryn and OP-1 Implant."

Prior to joining Omthera, from November 2007 until recently, Mr. Maines was Vice President Corporate Quality Assurance at MedImmune, LLC, where he oversaw a 200 person QA Operations team at six GMP manufacturing facilities in the U.S., UK and Netherlands.  From March 2000 to October 2007, Mr. Maines held various positions at GTC Biotherapeutics, including Vice President of Quality. While there, he was closely involved in the approval of the first product produced in transgenic dairy animals.

Mr. Maines' experience also includes Director of Quality at Stryker Corporation-Biotech Division; Director of Quality Assurance/Quality Control and Manager of Validation at Creative BioMolecules; and Manager of Quality Assurance at BioProcess
'/>"/>

SOURCE Omthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. HIV Prevention Expert Dr. Timothy Mastro Speaks on Future of Pre-Exposure Prophylaxis at International AIDS Conference
2. Timothy G. Hayes Appointed Head of Global Business Development for Bayer HealthCare Consumer Care
3. Timothy T. Goodnow, Ph.D., Joins Sensors for Medicine and Science, Inc. Board of Directors
4. WaferGen Appoints Industry Leader Dr. Timothy J. Triche to Board of Directors
5. Chimerix Appoints Timothy W. Trost Senior Vice President, Chief Financial Officer
6. Timothy Cote, MD, MPH, Joins NORD as Chief Medical Officer
7. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
8. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
9. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
10. Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination
11. MedicAlert Foundation Joins The Alzheimers Association to Offer MedicAlert(R) + Alzheimers Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... -- DURECT Corporation (Nasdaq: DRRX ) announced today ... healthcare conferences.  , James E. ... Rodman & Renshaw Investment Conference on Thursday, September 10 ... held at the St. Regis Hotel in ... of the presentation will be available by accessing ...
(Date:8/27/2015)... , Aug. 27, 2015 ieCrowd™ today ... the commercial development of the company,s supplemental oxygen ... Oxygen device, being developed by ieCrowd,s subsidiary Smart ... patient,s changing demand for oxygen based on level ... (k) submission for the Smart Oxygen device would ...
(Date:8/27/2015)... , Aug. 27, 2015  Eli Lilly and ... Stanley Global Healthcare Conference on Thursday, September 17, 2015. ... president of Lilly Oncology and Richard Gaynor , ... affairs for Lilly Oncology, will participate in a fireside ... A live audio webcast will be available on ...
Breaking Medicine Technology:DURECT to Participate in Upcoming Healthcare Conferences 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4Lilly to Participate in Morgan Stanley Global Healthcare Conference 2
(Date:8/29/2015)... ... August 30, 2015 , ... Electronic Informed Consent for ... 3:00 p.m. EDT, http://www.fdanews.com/electronicinformedconsent , The simple fact about electronic informed ... , Clinical trial sites can now use audio, video and interactivity to ...
(Date:8/29/2015)... PITTSBURGH, PA (PRWEB) , ... August 29, 2015 ... ... 1996," said one of two inventors from Miller Place, N.Y. "I specialize in ... pain and discomfort. In addition, it can be used for additional muscle dysfunction ...
(Date:8/29/2015)... ... August 29, 2015 , ... Targeted therapies, made ... the lives of patients, according to a newly published report. Surviving Mesothelioma has ... full article. , The authors of the new paper focus on several ...
(Date:8/29/2015)... ... 29, 2015 , ... Brands like Toppik , Eau Thermale Avene and ... “Before, a threshold of $49.00 was required to qualify for free standard shipping,” said ... standard shipping for customers regardless of the item’s selling price.” , With competitive pricing ...
(Date:8/29/2015)... ... 29, 2015 , ... ProDrop Particles includes over 40 particle backdrops designed for ... unique footage that users can shrink and stretch in the Final Cut Pro X ... customize color, brightness, scale, speed, range, and flare attributes with intuitive controls found in ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 3Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 4Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2
... the threats to themselves and relatives, study says , , FRIDAY, ... families in which some members have BRCA1 or 2 gene ... cancer -- typically avoid genetic counseling or testing, a new ... they,re less likely than women to pass on the information ...
... LOUIS, Feb. 27 Stereotaxis, Inc. (Nasdaq: ... Food and Drug Administration approved for marketing the NAVISTAR(R) ... Inc, a Johnson & Johnson company. The NAVISTAR(R) RMT ... Navigation System for mapping and radiofrequency (RF) ablation to ...
... N.J., Feb. 27 The Board of Directors of Schering-Plough ... dividend of 6.5 cents per common share. Payment will ... at the close of business on May 1, 2009. ... outstanding. The Board of Directors today also declared a quarterly ...
... of Long Term Care Workforce Put at Risk by FY ... LTC Sector to U.S. Economy, Jobs Base, Tax RevenueWASHINGTON, Feb. ... the nation,s long term care sector is a key driver ... revenue, state and national long term care leaders expressed alarm ...
... following is a statement by Robert Greenstein, Executive Director ... budget represents a bold and courageous proposal to make ... problems of our time -- a broken health care ... and other national needs.Particularly courageous are several proposals that ...
... FindingsNEWPORT NEWS, Va., Feb. 27 Women facing a ... the same or opposite breast with further testing using ... in the February 2009 "American Journal of Surgery." BSGI ... same or opposite breast in 10.9 percent of newly ...
Cached Medicine News:Health News:Men With BRCA Gene Mutations Unaware of Cancer Risks 2Health News:Men With BRCA Gene Mutations Unaware of Cancer Risks 3Health News:Stereotaxis Announces FDA Approval of the NAVISTAR(R) RMT THERMOCOOL(R) Catheter 2Health News:National, State Long Term Care Leaders Express Concern That FY 2010 Medicare Cuts Undermine, Contradict Intent of Economic Stimulus Law 2Health News:National, State Long Term Care Leaders Express Concern That FY 2010 Medicare Cuts Undermine, Contradict Intent of Economic Stimulus Law 3Health News:Statement by Robert Greenstein, Executive Director, Center on Budget and Policy Priorities, on the President's 2010 Budget Proposal 2Health News:Statement by Robert Greenstein, Executive Director, Center on Budget and Policy Priorities, on the President's 2010 Budget Proposal 3Health News:Statement by Robert Greenstein, Executive Director, Center on Budget and Policy Priorities, on the President's 2010 Budget Proposal 4Health News:Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Breast Cancer in Newly Diagnosed Breast Cancer Patients 2Health News:Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Breast Cancer in Newly Diagnosed Breast Cancer Patients 3
Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings. Ophtho-burr handpiece only. Battery powered handpiece....
Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings....
... Utilizing the most complex grinding ... accurate trial lens, are specifically ... quality and precision as the ... marco RT-300 refractor. Marco custom ...
Non-Illuminated Trial Lens Set with lenses mounted in plastic frames....
Medicine Products: